Hinova Pharmaceuticals Inc.
Clinical trials sponsored by Hinova Pharmaceuticals Inc., explained in plain language.
-
New pill aims to shrink fatty liver in 12 weeks
Disease control Recruiting nowThis study tests an experimental pill called HP515 for people with non-alcoholic fatty liver disease (NAFLD). About 80 adults aged 18 to 65 with at least 10% liver fat will take the drug for 12 weeks. The main goal is to see if it reduces liver fat measured by MRI, while also che…
Phase: PHASE2 • Sponsor: Hinova Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New pill takes on Hard-to-Treat prostate cancer
Disease control Recruiting nowThis study tests an experimental oral drug called HP518 in 84 men with metastatic castration-resistant prostate cancer that has spread and stopped responding to standard hormone therapy. The trial has two parts: first, finding the safest dose, then checking how well that dose con…
Phase: PHASE1, PHASE2 • Sponsor: Hinova Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC